antihyperglycemic [phsu]
therapy [ftcn]
Elderly [popg]
Patients [podg]
Type 2 Diabetes [dsyn]
Incretin [aapp, horm, phsu]
mimetics [bmod]
DPP-4 Inhibitors [moft]
Management [ocac]
Elderly [popg]
Patients [podg]
Type 2 Diabetes [dsyn]
Complicated [ftcn]
Age [orga]
Physiology [bmod]
Comorbidities [idcn]
Polypharmacy [fndg]
Heterogeneity [qlco]
Functional Status [fndg]
Minimum [qlco]
Goal [inpr]
antidiabetic [phsu]
treatment [ftcn]
glycemia [carb]
acute [tmco]
Complications [patf]
Diabetes [dsyn]
adverse effects [ftcn]
reduction [npop]
Quality [qlco]
Life [idcn]
Hypoglycaemia [dsyn]
Problem [fndg]
Elderly [popg]
Patients [podg]
Antidiabetic Agents [phsu]
Increased [qnco]
Hypoglycaemia [dsyn]
Addition [ftcn]
Standard [qlco]
Agent [chvf]
Risks [qlco]
Old [tmco]
Patients [podg]
Reduced [qlco]
Renal function [ortf]
Comorbidities [idcn]
New Agents [clas]
Based [ftcn]
Enhance [acty]
Incretin [aapp, horm, phsu]
activity [dora]
Including [ftcn]
Glucagon-Like Peptide 1 [aapp]
mimetics [bmod]
exenatide [aapp, phsu]
liraglutide [aapp, horm, phsu]
Oral [spco]
Dipeptidyl-Peptidase 4 Inhibitors [phsu]
sitagliptin [orch, phsu]
vildagliptin [orch, phsu]
Elderly [popg]
Patients [podg]
Diabetes [dsyn]
